Prelude Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-247,148
| Closed | -$3.99M | – | 1510 |
|
|
2020
Q4 | $3.99M | Buy |
+247,148
| New | +$3.99M | 0.1% | 51 |
|
|
2020
Q1 | – | Sell |
-46
| Closed | -$1K | – | 1785 |
|
|
2019
Q4 | $1K | Sell |
46
-120
| -72% | -$2.61K | ﹤0.01% | 1365 |
|
|
2019
Q3 | $2K | Sell |
166
-134
| -45% | -$1.61K | ﹤0.01% | 1120 |
|
|
2019
Q2 | $2K | Buy |
300
+107
| +55% | +$713 | ﹤0.01% | 1178 |
|
|
2019
Q1 | $2K | Sell |
193
-26
| -12% | -$269 | ﹤0.01% | 1293 |
|
|
2018
Q4 | $1K | Sell |
219
-33,244
| -99% | -$152K | ﹤0.01% | 1347 |
|
|
2018
Q3 | $402K | Buy |
+33,463
| New | +$402K | 0.02% | 388 |
|